Clinical Trial Update: A Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Participants With Acute Coronary Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial comparing rivaroxaban versus acetylsalicylic acid as add-on to clopidogrel or ticagrelor in acute coronary syndrome; study completed with results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• Acetylsalicylic acid (Aspirin)
• Rivaroxaban (rivaroxaban)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Acute Coronary Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2017-11-13